Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$111.9M
3 rounds on record
Latest round
$55M
Venture round · Oct 2023 · 2 yr ago
Team
6
US Form 5500 (plan participants) · Dec 2025 · +100% in a year
Backers
2
ARCH Venture Partners, Broadview Ventures
The money's age
Long since its last round
34 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
RoundDateAmountInvestorsSource
Venture round Oct 2023 $55M — SEC Form D
Venture round Oct 2023 $55M — SEC Form D
Venture round Aug 2020 $1.9M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Basking Biosciences, Inc. sec
Founders and leadersfrom filings, registers and the company's site
Richard SheaExecutive Officer, DirectorSEC Form D
Julia OwensExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Ironwoodpharma201-500 employees
Explore Ironwood Pharmaceuticals' commitment to GI health with innovative therapies, patient-focused research, and a vision to improve…
LifeMineVenture round $263M · 1 mo ago • Founded 2017 • 501-1000 employees • 1 role
LifeMine is a clinical-stage biopharmaceutical company pioneering a bold new approach, Top-Down Drug DiscoveryTM, which leverages…
ITM51-200 employees
At ITM, precision drives everything - from isotope manufacturing to cancer treatment—improving outcomes and delivering what patients and…
AlumisVenture round $40M · 2 yr ago • Founded 2021 • 11-50 employees • 4 roles
We are using a precision approach to develop therapies designed to transform the lives of patients with immune-mediated diseases.
KaileraFounded 2024 • 51-200 employees • 6 roles
Kailera is a late clinical-stage biotechnology company advancing a diversified pipeline of GLP-1 therapies to provide options for people…
Frontier Medicines is boldly advancing science to defeat disease by pioneering innovations in precision-based medicines to target…

Overview

Advancing reversible therapies targeting von Willebrand Factor for safer treatment of acute thrombotic conditions. Precision control when seconds matter.

People

Richard Shea
Executive Officer, Director
Julia Owens
Executive Officer, Director
Ryan Helon
Director
Thomas Needham
Director
Dan Myers
Director
Shahid Nimjee
Director
Bruce Sullenger
Director
Hannah Chang
Director
Aiden Aceves
Director
Steve Gillis
Director
David Adair
Director
Ari Nowacek
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cary United States
HQ
200-500 est. staff

Financials

Total raised
$111.9M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2023 $55M Details
Venture - Series Unknown 2023 $55M Details
Venture - Series Unknown 2020 $1.9M Details